Benitec Biopharma Inc. Share-based Payment Arrangement, Expense, Tax Benefit
Benitec Biopharma Inc. (BNTC) reported Share-based Payment Arrangement, Expense, Tax Benefit of $34.00 thousand for the 9-month period ending 2023-03-31, per its 10-K filed 2023-09-21.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2024-09-26
- Benitec Biopharma Inc. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $34.00K, a 0.00% change from fiscal 2021.
- Benitec Biopharma Inc. share-based payment arrangement, expense, tax benefit for fiscal 2021 was $34.00K.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|
| 2023-03-31 | $34.00K 10-K · filed 2023-09-21 | |
| 2022-06-30 | $34.00K 10-K · filed 2024-09-26 | |
| 2021-06-30 | $34.00K 10-K · filed 2024-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |